Optometrists in Greenwich, NY Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Old Saratoga Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1224 State Route 29, Greenwich, NY 12834 Phone: 518-692-2040 Fax: 518-692-2440 |
 Richard S Price, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: Route 29, Greenwich, NY 12834 Phone: 518-692-2960 Fax: 518-692-8826 |
 Dr. Angela E Gardner, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1224 State Route 29, Greenwich, NY 12834 Phone: 518-692-2040 Fax: 518-692-2440 |
News Archive
Bisphenol A chemical may shorten reproductive lifespan in women: Research
A study posted today (Wednesday, August 25) at the online site of the journal Biology of Reproduction reports that exposure of pregnant female mice to the endocrine-disrupting chemical bisphenol A may produce adverse reproductive consequences on gene expression in fetal ovaries as early as 12 hours after the mother has first been exposed to the chemical.
Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients
Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.
Janssen submits XARELTO sNDA with FDA to reduce risk of stent thrombosis in ACS patients
Janssen Research & Development, LLC announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO, an oral anticoagulant, to reduce the risk of stent thrombosis in patients with Acute Coronary Syndrome.
Blue Cross and Blue Shield FEP pharmacy benefit management program awarded to CVS Caremark
CVS Caremark Corporation today announced that it has been awarded a three-year contract to provide integrated pharmacy benefit services for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program (FEP), based on the best overall value.
› Verified 3 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists
Occupational Therapists